ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.

Every day two or three Canadians die of the disease.

Learn More About ALS

Help end ALS

 

    

 

 

 

ALS News

Highlights from Research Breakthroughs in 2011:

A Landmark Year in the History of ALS Research

While advances in ALS research over the past 3 years have been outstanding, 2011 was a year of multiple exciting breakthroughs many are calling a true turning point for ALS research worldwide. These new findings build on steady advances in fields as diverse as biomarkers

Read More »
Newly identified protein may play an important role in metabolic changes associated with ALS

A new series of studies conducted by Robert Kalb, MD, of the Children’s Hospital of Philadelphia and University of Philadelphia School of Medicine, and colleagues employed in vitro and in vivo models of ALS to establish a connection between expression of mutant SOD1 or TDP-43 and changes in key regulatory mechanisms for maintaining cellular energy levels.

Read More »
Join the LINC Study

Are you or someone you know living with a neurological condition? If so, join the LINC Study today.  This national study is designed to help researchers learn about the impact of living with a neurological condition.

Read More »
Ventilation education program helps with real-life decisions

After a 10-year period of analysis, Douglas A. McKim, MD, associate professor at the University of Ottawa, and colleagues at The Ottawa Hospital Rehabilitation Centre and Pembroke Regional

Read More »
FUS mutation can lead to Juvenile ALS

A study focusing on juvenile ALS (JALS) was published in the January 16 online issue of Archives of Neurology. This study was conducted by a team of Montreal researchers: Veronique

Read More »
Operating Grant: Winter 2012 Priority Announcement (Specific Research Areas)

CIHR - Operating Grant: Winter 2012 Priority Announcement (Specific Research Areas)

Read More »
All News